New Phase II trial data for roflumilast cream indicates a favorable safety profile and significant improvement in disease severity for infants with mild to moderate eczema, addressing a critical gap in pediatric dermatology.
As optimism returns to European markets, income-focused investors are turning to dividend stocks for resilience and yield. We analyze three European companies offering compelling payouts, weighing their potential against underlying risks in the current economic climate.
For those without children, retirement planning offers unique freedoms but demands heightened focus on long-term care and estate logistics. Experts warn that skipping these critical steps can lead to significant financial and legal pitfalls.
A 13-year-old boy swam four kilometers through treacherous waters off Western Australia's coast to alert rescuers after his mother and two siblings were swept out to sea, in an act described by emergency crews as "superhuman."
The reopening of Gaza's Rafah border crossing with Egypt, a key provision of the fragile ceasefire, has been mired by logistical delays and stringent security vetting. While hundreds of desperate Palestinians queue on both sides, the initial flow of medical evacuees and returnees falls drastically short of promised numbers, offering little respite for the territory's overwhelming humanitarian crisis.
The FDA has issued a complete response letter for Aquestive's sublingual epinephrine film Anaphylm, requesting new human factors studies. The company aims to resubmit its application by Q3 2026 while advancing regulatory efforts in Europe and Canada.
The AI-native platform for audit and advisory firms closes a Series C round led by Goldman Sachs, aiming to scale its model of human-AI collaboration in a $700 million valuation milestone.
Fluor Corporation's planned exit from its NuScale Power stake promises a major cash infusion, but analysts question whether it fundamentally alters the engineering giant's exposure to the boom-and-bust cycles of the construction industry.
As consumer sentiment sours, investors are pivoting to sectors like financial technology and home construction, anticipating policy moves from Washington aimed at easing cost-of-living pressures before the November elections.
The merger, set to create a premier gold-copper producer, targets significant production growth by 2026 and will maintain its headquarters in Vancouver under the Eldorado banner.
BMO Capital has increased its price target for Allstate (NYSE: ALL) from $244 to $249, maintaining a Buy rating. The firm points to lower catastrophe losses and a significant drop in reinsurance costs as key drivers for improved earnings visibility through 2026/27.
A landmark initiative in the UAE has tokenized over a quarter-billion dollars worth of polished diamonds onto the blockchain, leveraging Ripple's custody and ledger technology. The move signals a major step toward creating a regulated, institutional-grade trading platform for real-world assets in Dubai.
Amid a cautious market environment, a select group of penny stocks boasting market capitalizations over US$800 million and distinct financial profiles are drawing scrutiny from growth-oriented investors seeking value beyond conventional blue chips.
Virtuals Protocol has unveiled a novel '60 Days' framework, allowing early-stage Web3 founders to publicly test their tokens and products with a built-in exit option. The initiative comes as the protocol's native token, VIRTUAL, shows tentative signs of recovery amid recent market volatility.
The Financial Conduct Authority has imposed significant growth restrictions on insurance group Markerstudy, citing weaknesses in leadership and financial controls, a move that complicates its acquisition strategy and potential IPO.
A viral social media trend looking back at 2016 has sparked a sobering financial reality check. New analysis reveals the dramatic loss of purchasing power for what was once considered a lofty income milestone, with essential costs soaring far beyond headline inflation rates.
Shares of nutritional supplements maker USANA have tumbled over 25% in six months, trading near $21.66. While the valuation appears reasonable, underlying weaknesses in revenue growth and profitability are prompting investors to consider alternatives.
Tron founder Justin Sun sees AI as crypto's next frontier but argues the sector lacks a defining consumer application to ignite sustained growth, leaving established use cases like payments in the driver's seat.
China becomes the first nation to ban concealed door handles on electric vehicles, introducing new safety regulations following fatal incidents. The rules, effective from 2027, require physical release mechanisms and could reshape global automotive design standards.
Despite a 70% surge in its share price over six months, fueled by strong quarterly results, Rocket Lab (RKLB) faces significant financial headwinds. Analysts point to persistent negative cash flow, widening losses, and demanding valuations as reasons for caution, suggesting investors may find better opportunities elsewhere in the market.
